SCHEMBL5527345

SCHEMBL5527345

COC(=O)CN(CC1CCCCC1)C(=O)C(NC(=O)OC(C)(C)C)C(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSK P43235 3/20 0.42
CTSL P07711 2/20 0.42
CTSB P07858 1/20 0.42
CTSS P25774 2/20 0.41
CACNA1B Q00975 2/20 0.41
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA7 P43166 1/20 0.36
CYP2D6 P10635 1/20 0.36
KMT2A Q03164 2/20 0.35
PREP P48147 1/20 0.35
HDAC4 P56524 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
TSHR P16473 1/20 0.35
ELANE P08246 1/20 0.35
MEN1 O00255 1/20 0.35
ATM Q13315 1/20 0.35
EPHX1 P07099 1/20 0.34
REN P00797 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4665948 1.00 CTSK (0.42) CTSKCTSLCTSBCTSSCACNA1B
SCHEMBL5532292 0.99 CTSK (0.42) CTSKCTSLCTSBCTSSCACNA1B
SCHEMBL5532294 0.99 CTSK (0.42) CTSKCTSLCTSBCTSSCACNA1B
SCHEMBL4662787 0.90 CTSK (0.44) CTSKCTSLCTSBCTSSCACNA1B
SCHEMBL4662788 0.90 CTSK (0.44) CTSKCTSLCTSBCTSSCACNA1B
SCHEMBL4665932 0.89 CTSK (0.43) CTSKCTSLCTSBCTSSCACNA1B
SCHEMBL4665934 0.89 CTSK (0.43) CTSKCTSLCTSBCTSSCACNA1B
SCHEMBL7294947 0.83 CTSK (0.45) CTSKCTSSCACNA1BCYP2D6KMT2A
SCHEMBL8719646 0.83 CTSK (0.47) CTSKCTSSCACNA1BKMT2AHDAC4
SCHEMBL9543285 0.81 CTSK (0.50) CTSKCTSSCACNA1BHDAC4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070265281-A1 Organic Compounds and Their Uses COTTENS SYLVAIN 2007-11-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070265281-A1 Organic Compounds and Their Uses OAT, OTC, AOX1 CTSK 1630/4885CTSL 2124/4885CTSB 1766/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.